Sign in
WithdrawnNo phase

Long-term Registry of Patients Treated With Loncastuximab Tesirine

Key facts

Who runs it
ADC Therapeutics S.A.
Where
Fountain Valley, United StatesSee the site
Trial code
Status
Withdrawn
Started
30 Jun 2022
Ended
Jan 2025
Type of study
Observational
Record updated
22 June 2022
Why it stopped
Sponsor administrative decision

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Must be ≥ 18 years of age at the time of consent
  • Initiated or initiating commercially available loncastuximab tesirine treatment
  • Written informed consent must be obtained prior to any registry activities

Who cannot take part

  • Prior loncastuximab tesirine exposure in clinical trials

Where in United States

  • Compassionate Cancer Care Medical GroupFountain Valley, United States

About the trial

What the trial wants to find out

Retrospective and prospective multi-center observational study of patients with B-cell lymphomas treated with loncastuximab tesirine treatment in real-world practice.

The group in the trial

  • Patients Treated with Loncastuximab Tesirine

    Patients with B-cell lymphomas and other diagnoses who have been treated with loncastuximab tesirine will have their medical chart data entered into the registry.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Long-term Longitudinal Cohort Registry of Patients Treated With Loncastuximab Tesirine
Record updated
22 June 2022